We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva, Pfizer Reach Agreement on Generic Cancer Drugs, Antibiotic
Teva, Pfizer Reach Agreement on Generic Cancer Drugs, Antibiotic
November 21, 2006
Generic drug manufacturer Teva Pharmaceutical and its subsidiary Sicor will continue marketing the cancer drug idarubicin and the antibiotic azithromycin, the generic versions of Pfizer’s Idamycin and Zithromax, according to the terms of a settlement agreement the two companies reached this week.